Delhi High Court restrains generic pharmaceutical companies from making, selling Novartis' patented drug

The injunction order was passed against generic pharmaceutical companies that were manufacturing or selling Valsartan and Sacubitril tablets, a patented combination used to treat cardiovascular diseases.
Delhi High Court
Delhi High Court
Published on
3 min read

The Delhi High Court recently passed an injunction order restraining a slew of generic pharmaceutical firms including Windlas Biotech, Natco and Torrent Pharma from manufacturing or selling Valsartan and Sacubitril Tablets, patented in favour of Novartis (Novartis AG & Ors. v. NATCO Pharma Limited)

Loading content, please wait...
Bar and Bench - Indian Legal news
www.barandbench.com